Development of clinically relevant in vitro performance tests for powder inhalers
While realistic in vitro testing of dry powder inhalers (DPIs) can be used to establish in vitro–in vivo correlations (IVIVCs) and predict in vivo lung doses, the aerodynamic particle size distributions (APSDs) of those doses and their regional lung deposition remains unclear. Four studies were desi...
Main Author: | Wei, Xiangyin |
---|---|
Format: | Others |
Published: |
VCU Scholars Compass
2015
|
Subjects: | |
Online Access: | http://scholarscompass.vcu.edu/etd/4014 http://scholarscompass.vcu.edu/cgi/viewcontent.cgi?article=5066&context=etd |
Similar Items
-
In vitro dose comparison of Respimat® inhaler with dry powder inhalers for COPD maintenance therapy
by: Ciciliani A, et al.
Published: (2017-05-01) -
Investigations to identify the influence of the inhalation manoeuvre on the ex-vivo dose emission and the in-vitro aerodynamic dose emission characteristics of dry powder inhalers: Studies to identify the influence of inhalation flow, inhalation volume and the number of inhalations per dose on the ex-vivo dose emission and the in-vitro aerodynamic dose emission characteristics of dry powder inhalers.
by: Ibn Yakubu, Sani
Published: (2011) -
In-vitro inhalation performance for formoterol dry powder and metred dose inhalers. In-vitro characteristics of the emitted dose from the formoterol dry powder and metred dose inhalers to identify the influence of inhalation flow, inhalation volume and the number of inhalation per dose.
by: Alaboud, S.
Published: (2013) -
Theoretical and Experimental Behavior of Suspension Pressurized Metered Dose Inhalers
by: Sheth, Poonam
Published: (2014) -
Simple Method to Measure the Aerodynamic Size Distribution of Porous Particles Generated on Lyophilizate for Dry Powder Inhalation
by: Kahori Miyamoto, et al.
Published: (2020-10-01)